194 related articles for article (PubMed ID: 30251395)
21. Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.
Bassiri H; Benavides A; Haber M; Gilmour SK; Norris MD; Hogarty MD
Transl Pediatr; 2015 Jul; 4(3):226-38. PubMed ID: 26835380
[TBL] [Abstract][Full Text] [Related]
22. Polyamine depletion reduces TNFalpha/MG132-induced apoptosis in bone marrow stromal cells.
Muscari C; Bonafé F; Stanic I; Flamigni F; Stefanelli C; Farruggia G; Guarnieri C; Caldarera CM
Stem Cells; 2005 Aug; 23(7):983-91. PubMed ID: 15941855
[TBL] [Abstract][Full Text] [Related]
23. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
Kalemkerian GP; Slusher R; Ramalingam S; Gadgeel S; Mabry M
J Natl Cancer Inst; 1995 Nov; 87(22):1674-80. PubMed ID: 7473815
[TBL] [Abstract][Full Text] [Related]
24. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
[TBL] [Abstract][Full Text] [Related]
25. The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma.
Lovat PE; Corazzari M; Di Sano F; Piacentini M; Redfern CP
Cancer Lett; 2005 Oct; 228(1-2):105-10. PubMed ID: 15907365
[TBL] [Abstract][Full Text] [Related]
26. p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma.
Ganeshan VR; Schor NF
Cancer Chemother Pharmacol; 2014 Feb; 73(2):271-9. PubMed ID: 24253178
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response.
Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA
Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114
[TBL] [Abstract][Full Text] [Related]
28. Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO.
Diccianni MB; Kempińska K; Gangoti JA; Yu AL; Sorkin LS
PLoS One; 2020; 15(7):e0236115. PubMed ID: 32697811
[TBL] [Abstract][Full Text] [Related]
29. Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma.
Lovat PE; Ranalli M; Annichiarrico-Petruzzelli M; Bernassola F; Piacentini M; Malcolm AJ; Pearson AD; Melino G; Redfern CP
Exp Cell Res; 2000 Oct; 260(1):50-60. PubMed ID: 11010810
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells.
Yang B; Fan L; Fang L; He Q
Cancer Chemother Pharmacol; 2006 Oct; 58(4):540-6. PubMed ID: 16520989
[TBL] [Abstract][Full Text] [Related]
31. Difluoromethylornithine antagonizes taxol cytotoxicity in MCF-7 human breast cancer cells.
Das B; Rao AR; Madhubala R
Oncol Res; 1997; 9(11-12):565-72. PubMed ID: 9563003
[TBL] [Abstract][Full Text] [Related]
32. Decreased cytotoxicity of cis-diamminedichloroplatinum(II) by alpha-difluoromethylornithine depletion of polyamines in 9L rat brain tumor cells in vitro.
Oredsson SM; Deen DF; Marton LJ
Cancer Res; 1982 Apr; 42(4):1296-9. PubMed ID: 6800651
[TBL] [Abstract][Full Text] [Related]
33. DFMO Carbon Dots for Treatment of Neuroblastoma and Bioimaging.
Paudyal S; Vallejo FA; Cilingir EK; Zhou Y; Mintz KJ; Pressman Y; Gu J; Vanni S; Graham RM; Leblanc RM
ACS Appl Bio Mater; 2022 Jul; 5(7):3300-3309. PubMed ID: 35771033
[TBL] [Abstract][Full Text] [Related]
34. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
[TBL] [Abstract][Full Text] [Related]
35. Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma.
Koomoa DL; Yco LP; Borsics T; Wallick CJ; Bachmann AS
Cancer Res; 2008 Dec; 68(23):9825-31. PubMed ID: 19047162
[TBL] [Abstract][Full Text] [Related]
36. Combination therapy with 2-difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma.
Chen Y; Weeks RS; Burns MR; Boorman DW; Klein-Szanto A; O'Brien TG
Int J Cancer; 2006 May; 118(9):2344-9. PubMed ID: 16331620
[TBL] [Abstract][Full Text] [Related]
37. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.
Lovat PE; Oliverio S; Ranalli M; Corazzari M; Rodolfo C; Bernassola F; Aughton K; Maccarrone M; Hewson QD; Pearson AD; Melino G; Piacentini M; Redfern CP
Cancer Res; 2002 Sep; 62(18):5158-67. PubMed ID: 12234979
[TBL] [Abstract][Full Text] [Related]
38. BBC3 mediates fenretinide-induced cell death in neuroblastoma.
Wei JS; Whiteford CC; Cenacchi N; Son CG; Khan J
Oncogene; 2005 Dec; 24(54):7976-83. PubMed ID: 16091745
[TBL] [Abstract][Full Text] [Related]
39. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.
O'Shaughnessy JA; Demers LM; Jones SE; Arseneau J; Khandelwal P; George T; Gersh R; Mauger D; Manni A
Clin Cancer Res; 1999 Nov; 5(11):3438-44. PubMed ID: 10589756
[TBL] [Abstract][Full Text] [Related]
40. Induction of GADD153 and Bak: novel molecular targets of fenretinide-induced apoptosis of neuroblastoma.
Lovat PE; Oliverio S; Corazzari M; Ranalli M; Pearson AD; Melino G; Piacentini M; Redfern CP
Cancer Lett; 2003 Jul; 197(1-2):157-63. PubMed ID: 12880976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
